United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Report & Forecast 2021-2027

Publisher Name :
Date: 07-Sep-2021
No. of pages: 92
Inquire Before Buying

United States 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Dose)

United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Segment Percentages, By Type, 2020 (%)

- Single Dose Vial

- Pre-filled Syringe

United States 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Dose)

United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Segment Percentages, By Application, 2020 (%)

- For Children (2-10)

- For Person (10-64)

- For The Old (Above or equal to 65)

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies 23-Valent Pneumococcal Polysaccharide Vaccine revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies 23-Valent Pneumococcal Polysaccharide Vaccine revenues share in United States market, 2020 (%)

Key companies 23-Valent Pneumococcal Polysaccharide Vaccine sales in United States market, 2016-2021 (Estimated), (K Dose)

Key companies 23-Valent Pneumococcal Polysaccharide Vaccine sales share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- MSD

- Sanofipasteur

- CDIBP

United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 23-Valent Pneumococcal Polysaccharide Vaccine Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Overall Market Size
2.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Size: 2021 VS 2027
2.2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, Prospects & Forecasts: 2016-2027
2.3 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales: 2016-2027
3 Company Landscape
3.1 Top 23-Valent Pneumococcal Polysaccharide Vaccine Players in United States Market
3.2 Top United States 23-Valent Pneumococcal Polysaccharide Vaccine Companies Ranked by Revenue
3.3 United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Companies
3.4 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Companies
3.5 United States 23-Valent Pneumococcal Polysaccharide Vaccine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 23-Valent Pneumococcal Polysaccharide Vaccine Companies in United States Market, by Revenue in 2020
3.7 Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 23-Valent Pneumococcal Polysaccharide Vaccine Players in United States Market
3.8.1 List of Tier 1 23-Valent Pneumococcal Polysaccharide Vaccine Companies in United States
3.8.2 List of Tier 2 and Tier 3 23-Valent Pneumococcal Polysaccharide Vaccine Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Markets, 2021 & 2027
4.1.2 Single Dose Vial
4.1.3 Pre-filled Syringe
4.2 By Type - United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue & Forecasts
4.2.1 By Type - United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2016-2021
4.2.2 By Type - United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2022-2027
4.2.3 By Type - United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2016-2027
4.3 By Type - United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales & Forecasts
4.3.1 By Type - United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales, 2016-2021
4.3.2 By Type - United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales, 2022-2027
4.3.3 By Type - United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2016-2027
4.4 By Type - United States 23-Valent Pneumococcal Polysaccharide Vaccine Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2021 & 2027
5.1.2 For Children (2-10)
5.1.3 For Person (10-64)
5.1.4 For The Old (Above or equal to 65)
5.2 By Application - United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue & Forecasts
5.2.1 By Application - United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2016-2021
5.2.2 By Application - United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2022-2027
5.2.3 By Application - United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2016-2027
5.3 By Application - United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales & Forecasts
5.3.1 By Application - United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales, 2016-2021
5.3.2 By Application - United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales, 2022-2027
5.3.3 By Application - United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2016-2027
5.4 By Application - United States 23-Valent Pneumococcal Polysaccharide Vaccine Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 MSD
6.1.1 MSD Corporation Information
6.1.2 MSD Overview
6.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue in United States Market (2016-2021)
6.1.4 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product Description
6.1.5 MSD Recent Developments
6.2 Sanofipasteur
6.2.1 Sanofipasteur Corporation Information
6.2.2 Sanofipasteur Overview
6.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue in United States Market (2016-2021)
6.2.4 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product Description
6.2.5 Sanofipasteur Recent Developments
6.3 CDIBP
6.3.1 CDIBP Corporation Information
6.3.2 CDIBP Overview
6.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue in United States Market (2016-2021)
6.3.4 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Description
6.3.5 CDIBP Recent Developments
7 United States 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity, Analysis
7.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity, 2016-2027
7.2 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 23-Valent Pneumococcal Polysaccharide Vaccine Supply Chain Analysis
9.1 23-Valent Pneumococcal Polysaccharide Vaccine Industry Value Chain
9.2 23-Valent Pneumococcal Polysaccharide Vaccine Upstream Market
9.3 23-Valent Pneumococcal Polysaccharide Vaccine Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 23-Valent Pneumococcal Polysaccharide Vaccine Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of 23-Valent Pneumococcal Polysaccharide Vaccine in United States Market
Table 2. Top 23-Valent Pneumococcal Polysaccharide Vaccine Players in United States Market, Ranking by Revenue (2019)
Table 3. United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Companies, 2016-2021
Table 5. United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Companies, (K Dose), 2016-2021
Table 6. United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Price (2016-2021) & (US$/Dose)
Table 8. Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Product Type
Table 9. List of Tier 1 23-Valent Pneumococcal Polysaccharide Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 23-Valent Pneumococcal Polysaccharide Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Single Dose Vial
Table 12. Major Manufacturers of Pre-filled Syringe
Table 13. By Type - United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), 2016-2021
Table 17. By Type - United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), 2022-2027
Table 18. By Application - United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), 2016-2021
Table 22. By Application - United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), 2022-2027
Table 23. MSD Corporation Information
Table 24. MSD Description and Major Businesses
Table 25. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 26. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 27. MSD Recent Developments
Table 28. Sanofipasteur Corporation Information
Table 29. Sanofipasteur Description and Major Businesses
Table 30. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 31. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 32. Sanofipasteur Recent Developments
Table 33. CDIBP Corporation Information
Table 34. CDIBP Description and Major Businesses
Table 35. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 36. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 37. CDIBP Recent Developments
Table 38. 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity (K Dose) of Key Manufacturers in United States Market, 2019-2021 (K Dose)
Table 39. United States 23-Valent Pneumococcal Polysaccharide Vaccine Capacity Market Share of Key Manufacturers, 2019-2021
Table 40. 23-Valent Pneumococcal Polysaccharide Vaccine Market Opportunities & Trends in United States Market
Table 41. 23-Valent Pneumococcal Polysaccharide Vaccine Market Drivers in United States Market
Table 42. 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints in United States Market
Table 43. 23-Valent Pneumococcal Polysaccharide Vaccine Raw Materials
Table 44. 23-Valent Pneumococcal Polysaccharide Vaccine Raw Materials Suppliers in United States Market
Table 45. Typical 23-Valent Pneumococcal Polysaccharide Vaccine Downstream
Table 46. 23-Valent Pneumococcal Polysaccharide Vaccine Downstream Clients in United States Market
Table 47. 23-Valent Pneumococcal Polysaccharide Vaccine Distributors and Sales Agents in United States Market
List of Figures
Figure 1. 23-Valent Pneumococcal Polysaccharide Vaccine Product Picture
Figure 2. 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Type
Figure 3. 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Application
Figure 4. United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Overview: 2020
Figure 5. United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2016-2027 (US$, Mn)
Figure 7. 23-Valent Pneumococcal Polysaccharide Vaccine Sales in United States Market: 2016-2027 (K Dose)
Figure 8. The Top 3 and 5 Players Market Share by 23-Valent Pneumococcal Polysaccharide Vaccine Revenue in 2020
Figure 9. Single Dose Vial Product Picture
Figure 10. Pre-filled Syringe Product Picture
Figure 11. By Type - United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2016-2027
Figure 12. By Type - United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2016-2027
Figure 13. By Type - United States 23-Valent Pneumococcal Polysaccharide Vaccine Price (US$/Dose), 2016-2027
Figure 14. For Children (2-10)
Figure 15. For Person (10-64)
Figure 16. For The Old (Above or equal to 65)
Figure 17. By Application - United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2016-2027
Figure 18. By Application - United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2016-2027
Figure 19. By Application - United States 23-Valent Pneumococcal Polysaccharide Vaccine Price (US$/Dose), 2016-2027
Figure 20. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. United States 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity (K Dose), 2016-2027
Figure 24. 23-Valent Pneumococcal Polysaccharide Vaccine Industry Value Chain
Figure 25. Marketing Channels
  • Global Encephalitis Vaccination Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102
    According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......
  • Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123
    Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......
  • Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......
  • Global Avian Influenza Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155
    According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......
  • Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......
  • Global Influenza Vaccine Market Research Report 2023
    Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......
  • Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117
    Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......
  • Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......
  • 2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel
    Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107
    This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs